ÀüºÏ´ëÇб³º´¿ø(º´¿øÀå·Á¶³²Ãµ)Àº È£Èí±â¾Ë·¹¸£±â³»°ú ¹Ú½Â¿ë ±³¼ö(»çÁø)¿Í ¸ðÀ±´Ô °£È£»ç°¡ Á¦126Â÷ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Ãß°èÇмú´ëȸ¿¡¼ ‘¿ì¼öÃÊ·Ï»ó’À» ¼ö»óÇß´Ù°í 28ÀÏ ¹àÇû´Ù.
¹Ú½Â¿ë ±³¼öÆÀÀº ÀÌ´Þ ÃÊ ¼¿ï ·Ôµ¥È£ÅÚ¿ùµå¿¡¼ °³ÃÖµÈ 126Â÷ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Ãß°èÇмú´ëȸ¿¡¼ ‘ÁøÁ¤ ±â°üÁö³»½Ã°æ¿¡ ´ëÇÑ ·¹¹ÌÆæŸ´Ò ÁøÁ¤Á¦ÀÇ È¿´É ¹× ¾ÈÁ¤¼º:¹Ì´ÙÁ¹¶÷°ú ÇÁ·ÎÆ÷ÆúÀÇ ºñ±³¿¬±¸’(The efficacy and safety of remifentanil sedation(analgosedation) for diagnostic bronchoscopy: A comparative study with midazolam and propofol)¶ó´Â ÁÖÁ¦ÀÇ ³í¹®À» ¹ßÇ¥Çß´Ù.
À̹ø ¿¬±¸´Â ÀüºÏ´ëº´¿ø¿¡¼ 2015³â 5¿ùºÎÅÍ 2017³â 9¿ù±îÁö ÁøÇàµÈ ÁøÁ¤ ±â°üÁö³»½Ã°æ ȯÀÚ 200¿© ¸íÀ» ´ë»óÀ¸·Î, ±âÁ¸ ÁøÁ¤¾à¹°(midazolam+propofol) ´ëºñ ·¹¹ÌÆ柴Ò(remifentanyl)À̶ó´Â ÁøÁ¤¾à¹°ÀÇ ÀÓ»óÀûÀÎ È¿°ú¿Í ºÎÀÛ¿ëÀ» ºÐ¼®ÇÑ °ÍÀÌ´Ù.
¿¬±¸°á°ú remifentanylÀ» Àû¿ëÇÑ È¯ÀÚ±ºÀÌ ±âÁ¸ ¾à¹° ´ëºñ ºÎÀÛ¿ë ¹ß»ý¿¡´Â Å« Â÷ÀÌ°¡ ¾ø°í, ȸº¹½Ã°£ÀÌ »¡¶ó °íÀ§Ç豺(°í·É, ¸¸¼º ½ÉÆóÁúȯÀÚ µî)ÀÇ ±â°üÁö³»½Ã°æ ½ÃÇà ½Ã ¾ÈÀüÇÏ°í À¯¿ëÇÏ°Ô »ç¿ëµÉ ¼ö ÀÖ´Â °ÍÀ¸·Î È®ÀεƴÙ.
¹Ú½Â¿ë ±³¼ö´Â “ÇâÈÄ °íÀ§Çè ȯÀÚÀÇ ±â°üÁö³»½Ã°æ ÁøÇà ½Ã ±âÁ¸ ÁøÁ¤¾à¹° ´ëºñ ºÎÀÛ¿ë ¹ß»ý¿¡ Â÷ÀÌ°¡ ¾ø°í, ¹ß»ýÇÑ´Ù ÇÒÁö¶óµµ ÀÀ±Þ»óȲ ¹ß»ý ½Ã ȸº¹½Ã°£ÀÌ »¡¶ó ±âÁ¸ ¾à¹° ´ëºñ ¾ÈÀüÇÏ°Ô »ç¿ëµÉ ¼ö ÀÖÀ» °ÍÀÌ´Ù”°í ÀÇÀǸ¦ ¼³¸íÇß´Ù.
¹èÁØ¿ ±âÀÚ junjunjun2015@naver.com
<ÀúÀÛ±ÇÀÚ © ÀÇ»ç½Å¹®, ¹«´Ü ÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö>